Mucosal immunization with caseinolytic protease X elicited cross-protective immunity against pneumococcal infection in mice

Experimental Biology and Medicine

Volumn 237, Issue 6, 2012, Pages 694-702

  Zhong, Wen ^a   Xu, Wenchun ^a   Wang, Hong ^a   Huang, Yuanshuai ^a   Cao, Ju ^b   Gong, Yi ^a   Xu, Xiuyu ^a   Min, Xun ^a   Zhang, Yanqing ^a   Dong, Jie ^a   Yin, Yibing ^a   Zhang, Xuemei ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

ClpX; Heat shock protein; Mucosal immunity; Streptococcus pneumoniae; Vaccine

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CASEINOLYTIC PROTEASE 10; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BAGG ALBINO MOUSE; BIOINFORMATICS; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CROSS PROTECTION; FLOW CYTOMETRY; GENE; HUMAN; IMMUNIZATION; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PREDICTION; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CASEINS; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MICE; MICE, INBRED BALB C; PEPTIDE HYDROLASES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY MUCOSA; STREPTOCOCCUS PNEUMONIAE;

MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84863815959     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2012.011383     Document Type: Article

References (49)

1. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008;6:288-301
2. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lunberg U, Senn BM, Schunn M, Habel A, Henrigues-Normark B, Ortgvist A, Kalin M, von Gabain A, Nagy E. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 2008;205:117-31
3. Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189-209
4. Braido F, Bellotti M, De Maria A, Cazzola M, Canonica GW. The role of pneumococcal vaccine. Pulm Pharmacol Ther 2008;21:608-15
5. Fasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011;8:e1001017
6. Rodgers GL, Klugman PK. The future of pneumococcal disease prevention. Vaccine 2011;29S:C43-8
7. Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008;32:199-206
8. Swiatlo E, Ware D. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol Med Microbiol 2003;38:1-7
9. Alexander JE, Lock RA, Peeters CC, Poolman JT, Andrew PW, Mitchell TJ, Hansman D, Paton JC. Immunization of mice with pneumolysin toxid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 1994;62:5683-8
10. Arêas AP, Oliveria ML, Miyaji EN, Leite LC, Ho PL. Intradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae. Infect Immun 2005;73:3810-3
11. Brooks-Walter A, Briles DE, Hollingshead SK. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 1999;67:6533-42
12. Ferreira DM, Darrieux M, Silva DA, Leite LC, Ferreira JM Jr, Ho PL, Miyaji EN, Oliveira ML. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccine against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 2009;16:634-45
13. Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, Huebner RC, Virolainen A, Swiatlo E, Hollingshead SK. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 2000;68:798-800
14. Heeg C, Franken C, van der Linden M, Al-Lahham A, Reinert RR. Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children. Vaccine 2007;25:1030-5
15. Zü gel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999;12: 19-39
16. Bansal A, Paliwal PK, Sagi SS, Sairam M. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Saomonella typhi against S. typhi infection. Mol Cell Biochem 2010;337:213-21
17. Khan MN, Bansal A, Shukla D, Paliwal P, Sarada SK, Mustoori SR, Banerjee PK. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice. Vaccine 2006;24:6225-31
18. Shi C, Chen L, Chen Z, Zhang Y, Zhou Z, Lu J, Fu R, Wang C, Fang Z, Fan X. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 2010;28:5237-44
19. Zhang Q, Xu SX, Wang H, Xu WC, Zhang XM, Wu KF, Liu L, Yin YB. Contribution of ClpE to virulence of Streptococcus pneumoniae. Can J Microbiol 2009;55:1187-94
20. Frees D, Savijoki K, Varmanen P, Ingmer H. Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria. Mol Microbiol 2007;63:1285-95
21. Robertson GT, Ng WL, Gilmour R, Winkler ME. Essentiality of clpX, but not clpP, clpL, clpC, or clpE, in Streptococcus pneumoniae R6. J Bacteriol 2003;185:2961-6
22. Movahedi A, Hampson DJ. Distribution of the clpX gene in Brachyspira species and reactivity of recombinant Brachyspira pilosicoli ClpX with sera from mice and humans. J Med Microbiol 2007;56:930-6
23. Cui Y, Zhang X, Gong Y, Niu S, YinN, Yao R, XuW, Li D, Wang H, He Y, Cao J, Yin Y. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae. Vaccine 2011;29:1736-44
24. Mizrachi Nebenzahl Y, Bernstein A, Portnoi M, Shagan M, Rom S, Porgador A, Dagan R. Strepcococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesion, is able to induce a partially protective immune response in mice. J Infect Dis 2007;196:945-53
25. Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun 2008;76:2767-76
26. Yother J, White JM. Novel surface attachment mechanism of Streptococcus pneumoniae protein PspA. J Bacteriol 1994;176:2976-85
27. Terra VS, Homer KA, Rao SG, Andrew PW, Yesilkaya H. Characterization of novel b-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae. Infect Immun 2010;78:348-57
28. Gentile A, Bazán V. Prevention of pneumococcal disease through vaccination. Vaccine 2011;29:C15-25
29. Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol 2009;16:1709-19
30. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonization: the key to pneumococcal diseases. Lancet Infect Dis 2004;4:144-54
31. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14:801-7
32. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998;102:347-60
33. Austrain R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986;18:35-45
34. van Rossum AM, Lysenko ES, Weiser JN. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun 2005;73:7718-26
35. Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, Flechtner JB, Higgins DE, Malley R. TH17-based Vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 2011;9: 158-65
36. Basset A, ThompsonCM, HollingsheadSK, BrilesDE, AdesEW, LipsitchM, Malley R. Antibody-independent, CD4{thorn} T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 2007;75:5460-4
37. Fukuyama Y, King JD, Kataoka K, Kobayashi R, Gilgert RS, Oishi K, Hollingshead SK, Briles DE, Fujihashi K. Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol 2010;185:1755-62
38. Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA. Intranasal immunization promotes Th17 immune responses. J Immunol 2011;183:6933-8
39. Neutra MR, Kozlowshi PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006;6:148-58
40. ChoiCW, Lee YG, Kwon SO, KimHY, Lee JC, Chung YH, Yun CY, KimSI. Analysis of Streptococcus pneumoniae secreted antigens by immunoproteomic approach. Diagn Microbiol Infect Dis 2012;72:318-27
41. Divya Jyothi M, Garg SK, Singh NB. Mechanisms involved in protective immune response generated by secretory proteins of Mycobacterium habana against experimental tuberculosis. Scand J Immunol 2000;51:502-10
42. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP. Intranasal vaccination with a secreted Chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 2007;75:666-76
43. Li J, Xia J, Tan C, Zhou Y, Wang Y, Zheng C, Chen H, Bei W. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2. Vaccine 2011;29:6514-9
44. Moffitt KL, Malley R. Next generation pneumococcal vaccines. Curr Opin Immunol 2011;23:407-13
45. Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L, Wang H, Zhang H, Wang L, Chu Y, Liu Y, Ni Y. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis 2008;61: 256-63
46. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 2007;75:350-7
47. Wu K, Zhang X, Shi J, Li N, Li D, Luo M, Cao J, Yin N, Wang H, Xu W, He Y, Yin Y. Immunization with a combination of three pneumococcal proteins confers additive and broad protection agaist Streptococcus pneumoniae infection in mice. Infect Immun 2010;78:1276-83
48. Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun 2000;68:3028-33
49. Gong Y, Xu W, Cui Y, Zhang X, Yao R, Li D, Wang H, He Y, Cao J, Yin Y. Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice. Infect Immun 2011; 79:867-78